GlassScriptPhysician profile
Bruce A Edelman
NPI 1639276009
$1,033.47
in general payments reported to CMS, 2019-2025
18 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.42 · 2020: $192 · 2021: $267 · 2022: $65.84 · 2023: $60.92 · 2024: $108 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $276.59 | 2019-2025 | |
| Glaxosmithkline, LLC. | $188.92 | 2019-2025 | Nucala |
| Optinose US, INC. | $129.88 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $79.10 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.90 | 2020-2025 | Cuvitru, Eohilia |
| Regeneron Healthcare Solutions, INC. | $47.97 | 2021-2025 | Dupixent |
| Alk-Abello, INC | $40.69 | 2019-2020 | |
| Lilly USA, LLC | $38.51 | 2025 | Ebglyss |
| Boston Scientific Corporation | $23.84 | 2023 | Varithena Administration Pack |
| Ambu INC. | $23.70 | 2022 | |
| Acclarent, INC | $19.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.48 | 2025 | Tezspire |
| Intersect Ent, INC. | $15.00 | 2020 | |
| Incyte Corporation | $14.26 | 2021 | |
| Kaleo, INC. | $13.90 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $13.29 | 2021 | |
| Genentech USA, INC. | $13.13 | 2024 | Xolair |
| Shire North American Group INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Edelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.